Back to top
more

CoDiagnostics (CODX)

(Delayed Data from NSDQ)

$1.17 USD

1.17
33,658

+0.02 (1.74%)

Updated Aug 13, 2024 04:00 PM ET

After-Market: $1.16 -0.01 (-0.85%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value C Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 41% (147 out of 250)

Industry: Medical Services

Better trading starts here.

Zacks News

CoDiagnostics Inc (CODX) Gains As Market Dips: What You Should Know

CoDiagnostics Inc (CODX) closed at $17.11 in the latest trading session, marking a +0.38% move from the prior day.

Is Co-Diagnostics (CODX) Stock Outpacing Its Medical Peers This Year?

Is (CODX) Outperforming Other Medical Stocks This Year?

Company News for Apr 21, 2020

Companies In The News Are: CYCC, CODX, NBY, EXEL

Implied Volatility Surging for Co-Diagnostics (CODX) Stock Options

Investors need to pay close attention to Co-Diagnostics (CODX) stock based on the movements in the options market lately.

Urmimala Biswas headshot

Medical Services Outlook Bright Amid Coronavirus Crisis

Despite the coronavirus-led worldwide sales disruption, medical services is one of the few sectors witnessing industry-wide growth right now.

Is Co-Diagnostics (CODX) Outperforming Other Medical Stocks This Year?

Is (CODX) Outperforming Other Medical Stocks This Year?

The Zacks Analyst Blog Highlights: Co-Diagnostics, VAXART, Zoom Video, CrowdStrike and Domino's

The Zacks Analyst Blog Highlights: Co-Diagnostics, VAXART, Zoom Video, CrowdStrike and Domino's

Co-Diagnostics, Inc. (CODX) Moves to Strong Buy: Rationale Behind the Upgrade

Co-Diagnostics, Inc. (CODX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Sanghamitra Saha headshot

Top Sectors of Q1 & Their Winning Stocks

Inside the top-performing sectors of Q1 and their winning stocks.

Sanghamitra Saha headshot

Coronavirus Scare Supports These Biotech ETFs & Stocks

Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.

The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics

The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics

Coronavirus Test Kit Demand to Drive These 3 Stocks

Point-of-care testing enables better patient triage, bed management, and patient care decisions. Here are three stocks to benefit as demand rises.

Has Co-Diagnostics (CODX) Outpaced Other Medical Stocks This Year?

Is (CODX) Outperforming Other Medical Stocks This Year?

The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Co-Diagnostics, Moderna and Vertex Pharmaceuticals

The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Co-Diagnostics, Moderna and Vertex Pharmaceuticals

Tirthankar Chakraborty headshot

4 Top Biotech Stocks to Buy in the Time of Coronavirus

We have picked biotech companies that are widely expected to develop a vaccine for the coronavirus and fight off the worst stock market carnage since the 2008 financial crisis.

The Zacks Analyst Blog Highlights: Netflix, Microsoft, Sempra Energy, Co-Diagnostics and Moderna

The Zacks Analyst Blog Highlights: Netflix, Microsoft, Sempra Energy, Co-Diagnostics and Moderna

Top Ranked Momentum Stocks to Buy for March 16th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 16th.

Tirthankar Chakraborty headshot

5 Smart Ways to Profit From the Coronavirus Crisis

Even though majority of investors are in a state of shock, many know how to profit during uncertain times like these. Here're five ways you can put your money to work amid the coronavirus outbreak.

Sanghamitra Saha headshot

Beat Virus With 2 Sector ETFs & Stocks That Survived 2008 Crisis

These two sectors lost lesser than the broader market during the 2008 financial crisis and may help you to tide over the latest virus crisis.

The Zacks Analyst Blog Highlights: Co-Diagnostics, GenMark Diagnostics, OPKO Health and Inovio Pharmaceuticals

The Zacks Analyst Blog Highlights: Co-Diagnostics, GenMark Diagnostics, OPKO Health and Inovio Pharmaceuticals

The Zacks Analyst Blog Highlights: Buckle, Chipotle Mexican Grill, Co-Diagnostics, Moderna and Regeneron Pharmaceuticals

The Zacks Analyst Blog Highlights: Buckle, Chipotle Mexican Grill, Co-Diagnostics, Moderna and Regeneron Pharmaceuticals

Nilanjan Banerjee headshot

4 Stocks to Gain the Most From the Coronavirus Outbreak

It is worthwhile to keep an eye on stocks of companies that are engaged in the prevention, diagnosis and treatment of the disease.

Tirthankar Chakraborty headshot

5 Stocks to Win Big From Trump's Economic Stimulus

Trump floats financial aids to counter the impact of the coronavirus outbreak. Notable stimulus measures include payroll tax cut, aid for wage earners and an emergency funding worth $8.3 billion

Co-Diagnostics, Inc. (CODX) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Co-Diagnostics, Inc. (CODX).

Top Ranked Momentum Stocks to Buy for March 10th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 10th